Similar articles

• Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly.

  Coiffier B. Coiffier B. Semin Oncol. 2003 Feb;30(1 Suppl 2):21-7. doi: 10.1053/sonc.2003.50021. Semin Oncol. 2003. PMID: 12652461 Review.
• Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphoma.

  Bieker R, Kessler T, Berdel WE, Mesters RM. Bieker R, et al. Oncol Rep. 2003 Nov-Dec;10(6):1915-7. doi: 10.3892/or.10.6.1915. Oncol Rep. 2003. PMID: 14534718
• Second treatment with rituximab in B-cell non-Hodgkin's lymphoma: efficacy and toxicity on 41 patients treated at CHU-Lyon Sud.

  Lemieux B, Bouafia F, Thieblemont C, Hequet O, Arnaud P, Tartas S, Traulle C, Salles G, Coiffier B. Lemieux B, et al. Hematol J. 2004;5(6):467-71. doi: 10.1038/sj.thj.6200559. Hematol J. 2004. PMID: 15570286
• Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma.

  Coiffier B. Coiffier B. Semin Oncol. 2002 Apr;29(2 Suppl 6):18-22. doi: 10.1053/sonc.2002.32749. Semin Oncol. 2002. PMID: 12040530 Review.
• Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation.

  Pan D, Moskowitz CH, Zelenetz AD, Straus D, Kewalaramani T, Noy A, Qin J, Teruya-Feldstein J, Portlock CS. Pan D, et al. Cancer J. 2002 Sep-Oct;8(5):371-6. doi: 10.1097/00130404-200209000-00007. Cancer J. 2002. PMID: 12416894